Jaguar Animal Health (NASDAQ:JAGX) Releases Quarterly Earnings Results, Beats Estimates By $435.06 EPS

Jaguar Animal Health (NASDAQ:JAGX – Get Free Report) issued its earnings results on Monday. The biotechnology company reported ($9.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($444.29) by $435.06, FiscalAI reports. The business had revenue of $2.34 million during the quarter, compared to the consensus estimate of $4.85 million.

Jaguar Animal Health Stock Performance

NASDAQ:JAGX opened at $0.42 on Monday. Jaguar Animal Health has a twelve month low of $0.36 and a twelve month high of $1,039.50. The company has a quick ratio of 0.40, a current ratio of 0.69 and a debt-to-equity ratio of 0.35. The stock’s 50-day simple moving average is $4.09 and its 200 day simple moving average is $101.51. The firm has a market capitalization of $816,660.00, a PE ratio of -0.00 and a beta of -0.09.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Wall Street Zen upgraded Jaguar Animal Health to a “sell” rating in a report on Saturday, October 10th. Weiss Ratings restated a “sell (e+)” rating on shares of Jaguar Animal Health in a report on Thursday, October 15th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat, Jaguar Animal Health currently has a consensus rating of “Sell”.

View Our Latest Analysis on JAGX

Jaguar Animal Health Company Profile

(Get Free Report)

Jaguar Health, Inc., formerly Jaguar Animal Health, develops prescription medicines for gastrointestinal disorders in humans and animals. The company’s research has focused on plant-derived compounds, including crofelemer, which is derived from the Croton lechleri tree. Jaguar’s animal-health product Canalevia-CA1 received FDA conditional approval for the treatment of chemotherapy-induced diarrhea in dogs. The company also develops and commercializes crofelemer-based medicines for human gastrointestinal conditions.

Read More

Earnings History for Jaguar Animal Health (NASDAQ:JAGX)

Receive News & Ratings for Jaguar Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.